MedPath

Multicomponent Therapy for Fibromyalgia

Not Applicable
Completed
Conditions
Fibromyalgia
Registration Number
NCT03319355
Lead Sponsor
University Ghent
Brief Summary

Therapy for fibromyalgia is a well discussed topic in literature, yet not thoroughly evidence-based. Several unicomponent therapies seem to be benificial. Whereas multicomponent and multidisciplinary therapy gains importance and revealing promising results, the investigators aim to combine two well-known therapies in a program for patients with fibromyalgia.

From clinical experience, a high drop-out rate has been stated. All data will be explored to analyse explanatory factors.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
136
Inclusion Criteria
  • woman with fibromyalgia
  • between the age of 20 and 50
  • agreement with therapy protocol
Exclusion Criteria
  • high indication of depression measured with the Beck Depression Index

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Walking6 weeks

6 minute walking test on a treadmill

Tampa scale for kinesiophobia6weeks

rating the kinesiophobia with a questionnaire

Grip strength6 weeks

measuring grip strength of both hands with a dynamometer

Fibromyalgia Impact Questionnaire6weeks

impact of fibromyalgia on daily life with a questionnaire

Pain Coping Inventory6 weeks

inventory of the use of pain coping strategies with a questionnaiire

cycling6 weeks

10 minutes cycling test on a hometrainer

Beck Depression Index6 weeks

degree of depression with a questionnaire

Pain at tenderpoints6 weeks

measuring tolerable pain at specified tenderpoints with an algometer

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath